【摘 要】
：
Purpose: We investigated the significance of CD24 and CD44 expression for predicting responses to chemotherapy and prognosis in primary breast cancer patients.Patients and Methods: Diagnosis of breast
【机 构】
：
Breast Oncology Unit Cancer and Infectious Diseases Center of Tokyo Metropolitan Komagome Hospital J
【出 处】
：
(BITs 3rd Annual World Cancer Congress-2010, Breast Cancer C
论文部分内容阅读
Purpose: We investigated the significance of CD24 and CD44 expression for predicting responses to chemotherapy and prognosis in primary breast cancer patients.Patients and Methods: Diagnosis of breast cancer was confirmed by core needle biopsy, and immunohistochemical studies were performed.Preoperatively, patients received anthracyclinecontaining chemotherapy.Expression of CD44 and CD24 was assessed immunohistochemically and the relationship with chemotherapy response and with prognosis was analyzed.Results: Between 2001 and 2004, 139 women were enrolled in this study.In the correlation analysis, CD24 expression was negatively associated with pathological response to chemotherapy (p=0.0003).A machine learning technique with an alternating decision tree (ADTree) showed that four logical rules are involved in predicting the response depending on the combination of CD24, HER2, tumor stage,CD44, progesterone receptor, and patient age.In the survival analysis, patients having CD44 (++) showed a significantly favorable prognosis as compared with others (p=0.0002).A multivariate analysis showed that CD44 expression had an independent prognostic value (p<0.001).Conclusion: We found a significant correlation between CD44 expression and prognosis and between CD24 expression and response to chemotherapy.CD24 and CD44 expressions would be useful predictive markers, although further studies are needed.
其他文献
Dr.Roberts will address general questions arising firom his long standing interests in kinases in cancer, with a particular emphasis on the PI3Kinase pathway.
African-American (AA) and premenopausal patients have been shown to have poorer stage for stage survival than the overall population.Hispanic females at our institution have been found to have lower g
Women carrying germline BRCA1/2 deleterious mutations are an extreme risk population for developing breast cancer,with a cumulative life-time risk of 56-80%.Prophylactic bilateral mastectomy provides
Breast carcinomas are highly heterogeneous, with many different pathological subtypes and recently described molecular subtypes.This heterogeneity among tumors occurring in different patients should n
Gene expression profiling using microarrays combined with qPCR has created new possibilities for the molecular characterisation of breast cancer.We have completed whole genome microarray analysis of >
Since the diagnostic value of the vessel parameters maximum velocity, pulsatility index and min RI has been found to be limited, power Doppler, a different method of signal processing, was developed t
Breast cancer is the commonest type of malignancy to affect women in western countries.In India, is the commonest cancer to affect women of metropolitan cities with over 80,000 new cases diagnosed eac
In 2006, the American Cancer Society estimated that one in eight women in the US was diagnosed with breast cancer,making the illness the second leading cause of death among women, after lung cancer.Al
High-resolution MRI, particularly dynamic contrast-enhanced MRI (DCE-MRI), provides high sensitivity for the detection of breast lesions and is routinely used on clinical (1.5 Tesla) scanners.Recent s
Biologic markers that predict presence or subsequent development of invasive disease in patents diagnosed with ductal carcinoma in-situ (DCIS) are needed for more personalized targeted treatment.Subcl